Common use of Challenge to Patent Rights Clause in Contracts

Challenge to Patent Rights. If DERMA, directly or indirectly, by itself or through one of its Affiliates, brings any action or proceeding without "Cause" (defined below) challenging the validity, enforceability or an interference action of or with respect to any of the Patent Rights (a “Challenge”), then QMT shall have the right to terminate this Agreement at any time following such event upon written notice. "Cause", for purposes of the preceding sentence, shall mean (i) any third party claim, action or suit filed or brought in any applicable court or through any administrative procedure against DERMA, or (ii) the withholding of payment for the Products by customers of DERMA, which in each case presented in clause (i) and/or (ii) above is predicated upon the invalidity of the Patent Rights, which has, or if successfully prosecuted could reasonably be expected to have, a material adverse effect upon DERMA. ***** This material has been omitted pursuant to a request for confidential treatment and filed separately with the Securities and Exchange Commission.

Appears in 1 contract

Sources: Patent and Technology License Agreement (Quick Med Technologies Inc)

Challenge to Patent Rights. If DERMA, directly or indirectly, by itself or through one of its Affiliates, brings any action or proceeding without "Cause" (defined below) challenging the validity, enforceability or an interference action of or with respect to any of the Patent Rights (a “Challenge”), then QMT shall have the right to terminate this Agreement at any time following such event upon written notice. "Cause", for purposes of the preceding sentence, shall mean (i) any third party claim, action or suit filed or brought in any applicable court or through any administrative procedure against DERMA, or (ii) the withholding of payment for the Products by customers of DERMA, which in each case presented in clause (i) and/or (ii) above is predicated upon the invalidity of the Patent Rights, which has, or if successfully prosecuted could reasonably be expected to have, a material adverse effect upon DERMA. ***** This material has been omitted pursuant to a request for confidential treatment and filed separately with the Securities and Exchange Commission.

Appears in 1 contract

Sources: Patent and Technology License Agreement (Quick Med Technologies Inc)

Challenge to Patent Rights. If DERMA, directly or indirectly, by itself or through one of its Affiliates, brings any action or proceeding without "Cause" (defined below) challenging the validity, enforceability or an interference action of or with respect to any of the Patent Rights (a “Challenge”), then QMT shall have the right to terminate this Agreement at any time following such event upon written notice. "Cause", for purposes of the preceding sentence, shall mean (i) any third party claim, action or suit filed or brought in any applicable court or through any administrative procedure against DERMA, or (ii) the withholding of payment for the Products by customers of DERMA, which in each case presented in clause (i) and/or (ii) above is predicated upon the invalidity of the Patent Rights, which has, or if successfully prosecuted could reasonably be expected to have, a material adverse effect upon DERMA. ***** This material has been omitted pursuant to a request for confidential treatment and filed separately with the Securities and Exchange Commission.

Appears in 1 contract

Sources: Patent and Technology License Agreement (Derma Sciences, Inc.)